Patents by Inventor Steven Geoffrey Aitken

Steven Geoffrey Aitken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Macrocyclic cysteine protease inhibitors and compositions thereof
    Patent number: 9434762
    Abstract: The present invention provides a novel class of macrocyclic compounds, which are useful as cysteine protease inhibitors. Also provided are novel intermediates and methods of preparing the compounds. The invention also provides pharmaceutical compositions comprising the compounds. The compounds and compositions are useful in methods of treating or preventing one or more diseases associated with cysteine protease activity, particularly those associated with calpain activity.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: September 6, 2016
    Assignees: UNIVERSITY OF CANTERBURY, LINCOLN UNIVERSITY, DOUGLAS PHARMACEUTICALS LIMITED
    Inventors: Andrew David Abell, James Morriss Coxon, Matthew Alan Jones, Stephen Brian McNabb, Axel Thomas Neffe, Steven Geoffrey Aitken, Blair Gibb Stuart, Janna Marie Nikkel, Joanna Kimberley Duncan, Mutita Klanchantra, James David Morton, Roy Bickerstaffe, Lucinda Jane Goodricke Robertson, Hannah Yun Young Lee, Matthew Stewart Muir
  • Macrocyclic Cysteine Protease Inhibitors and Compositions Thereof
    Publication number: 20140194362
    Abstract: The present invention provides a novel class of macrocyclic compounds, which are useful as cysteine protease inhibitors. Also provided are novel intermediates and methods of preparing the compounds. The invention also provides pharmaceutical compositions comprising the compounds. The compounds and compositions are useful in methods of treating or preventing one or more diseases associated with cysteine protease activity, particularly those associated with calpain activity.
    Type: Application
    Filed: March 12, 2014
    Publication date: July 10, 2014
    Applicants: Lincoln University, Douglas Pharmaceuticals Limited, Canterprise Limited
    Inventors: Andrew David Abell, James Morriss Coxon, Matthew Alan Jones, Stephen Brian McNabb, Axel Thomas Neffe, Steven Geoffrey Aitken, Blair Gibb Stuart, Janna Marie Nikkel, Joanna Kimberley Duncan, Mutita Klanchantra, James David Morton, Roy Bickerstaffe, Lucinda Jane Goodricke Robertson, Hannah Yun Young Lee, Matthew Stewart Muir
  • Macrocyclic cysteine protease inhibitors and compositions thereof
    Patent number: 8710178
    Abstract: The present invention provides a novel class of macrocyclic compounds, which are useful as cysteine protease inhibitors. Also provided are novel intermediates and methods of preparing the compounds. The invention also provides pharmaceutical compositions comprising the compounds. The compounds and compositions are useful in methods of treating or preventing one or more diseases associated with cysteine protease activity, particularly those associated with calpain activity.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: April 29, 2014
    Assignees: Lincoln University, Canterprise Limited, Douglas Pharmaceuticals Limited
    Inventors: Andrew David Abell, James Morriss Coxon, Matthew Alan Jones, Stephen Brian McNabb, Axel Thomas Neffe, Steven Geoffrey Aitken, Blair Gibb Stuart, Janna Marie Nikkel, Joanna Kimberley Duncan, Mutita Klanchantra, James David Morton, Roy Bickerstaffe, Lucinda Jane Goodricke Robertson, Hannah Yun Young Lee, Matthew Stewart Muir
  • Macrocyclic Cysteine Protease Inhibitors and Compositions Thereof
    Publication number: 20110021434
    Abstract: The present invention provides a novel class of macrocyclic compounds, which are useful as cysteine protease inhibitors. Also provided are novel intermediates and methods of preparing the compounds. The invention also provides pharmaceutical compositions comprising the compounds. The compounds and compositions are useful in methods of treating or preventing one or more diseases associated with cysteine protease activity, particularly those associated with calpain activity.
    Type: Application
    Filed: October 18, 2007
    Publication date: January 27, 2011
    Inventors: Andrew David Abell, James Morriss Coxon, Matthew Alan Jones, Stephen Brian McNabb, Axel Thomas Neffe, Steven Geoffrey Aitken, Blair Gibb Stuart, Janna Marie Nikkel, Joanna Kimberley Duncan, Mutita Klanchantra, James David Morton, Roy Bickerstaffe, Lucinda Jane Goodricke Robertson, Hannah Yun Young Lee, Matthew Stewart Muir
  • KERATIN DERIVATIVES AND METHODS OF MAKING THE SAME
    Publication number: 20100330019
    Abstract: Soluble keratin derivatives are disclosed. The soluble keratin derivatives may include a soluble keratin protein having at least one substituted chemical group at a lysine group, terminal amine group and/or hydroxyl amino acid group of a soluble keratin protein. Soluble keratin derivatives may be formed by succinylation or quaternisation, or by reaction with fatty acid derivatives. The soluble keratin derivatives may be used in personal care formulations, and may also comprise mixtures of several different soluble keratin derivatives.
    Type: Application
    Filed: October 31, 2008
    Publication date: December 30, 2010
    Inventors: Robert James Kelly, Sonya Mary Scott, Alisa Dawn Roddick-Lanzilotta, Steven Geoffrey Aitken
  • NOVEL POLYMORPH OF (5-AMINO-6-METHOXY-3-PYRIDINCARBONYL) CARBAMIC ACID 2-(S)-HYDROXYMUTILIN 14-ESTER
    Publication number: 20090291987
    Abstract: The present invention relates to a novel polymorph, to processes for the preparation of the polymorph and to the use of the polymorph in medicine, particularly antibacterial therapy.
    Type: Application
    Filed: December 9, 2005
    Publication date: November 26, 2009
    Inventors: Steven Geoffrey Aitken, Steven Dabbs, Eric Hunt
  • KERATIN DERIVATIVES AND METHODS OF MAKING THE SAME
    Publication number: 20090111750
    Abstract: Soluble keratin derivatives are disclosed. The soluble keratin derivatives may include a soluble keratin protein having at least one substituted chemical group at a lysine group, terminal amine group and/or hydroxyl amino acid group of a soluble keratin protein. Soluble keratin derivatives may be formed by succinylation or quaternisation, or by reaction with fatty acid derivatives. The soluble keratin derivatives may be used in personal care formulations, and may also comprise mixtures of several different soluble keratin derivatives.
    Type: Application
    Filed: October 31, 2008
    Publication date: April 30, 2009
    Applicant: Keratec, LTD.
    Inventors: Robert James Kelly, Sonya Mary Scott, Alisa Dawn Roddick-Lanzilotta, Steven Geoffrey Aitken